LAUREN BOND: Open Payments
NPI 1245740158 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,839 in 192 payments from 27 companies in 2025. Trend: 2023 $4,813 · 2024 $5,272 · 2025 $4,839
Food & beverage: $4,821Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 39 | $1,238 |
| GlaxoSmithKline, LLC. | 29 | $507 |
| GENZYME CORPORATION | 9 | $428 |
| Regeneron Healthcare Solutions, Inc. | 13 | $369 |
| JAZZ PHARMACEUTICALS INC. | 9 | $289 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $197 |
| United Therapeutics Corporation | 8 | $179 |
| Insmed, Inc. | 11 | $179 |
| Inspire Medical Systems, Inc. | 6 | $178 |
| Grifols USA, LLC | 7 | $168 |
Products named: DUPIXENT, BREZTRI, NUCALA, XYWAV, TEZSPIRE, TRELEGY ELLIPTA, Tyvaso, INSPIRE.
Industry payments across FL — which companies pay providers there.
